Freenome
Early cancer detection company developing blood-based screening tests using multiomics and AI; SimpleScreen CRC received FDA approval in July 2026.
Cancer Screening · Blood-based multiomics / AI / machine learning · Commercial
Early cancer detection company developing blood-based screening tests using multiomics and AI; SimpleScreen CRC received FDA approval in July 2026.
Cancer Screening · Blood-based multiomics / AI / machine learning · Commercial